Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Characterization of ADME genes variation in Roma and 20 populations worldwide.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
- Publication Information:
Original Publication: San Francisco, CA : Public Library of Science
- Subject Terms:
- Abstract:
The products of the polymorphic ADME genes are involved in Absorption, Distribution, Metabolism, and Excretion of drugs. The pharmacogenetic data have been studied extensively due to their clinical importance in the appropriate drug prescription, but such data from the isolated populations are rather scarce. We analyzed the distribution of 95 polymorphisms in 31 core ADME genes in 20 populations worldwide and in newly genotyped samples from the Roma (Gypsy) population living in Croatia. Global distribution of ADME core gene loci differentiated three major clusters; (1) African, (2) East Asian, and (3) joint European, South Asian and South American cluster. The SLCO1B3 (rs4149117) and CYP3A4 (rs2242480) genes differentiated at the highest level the African group of populations, while NAT2 gene loci (rs1208, rs1801280, and rs1799929) and VKORC1 (rs9923231) differentiated East Asian populations. The VKORC1 rs9923231 was among the investigated loci the one with the largest global minor allele frequency (MAF) range; its MAF ranged from 0.027 in Nigeria to 0.924 in Han Chinese. The distribution of the investigated gene loci positions Roma population within the joined European and South Asian clusters, suggesting that their ADME gene pool is a combination of ancestral (Indian) and more recent (European) surrounding, as it was already implied by other genetic markers. However, when compared to the populations worldwide, the Croatian Roma have extreme MAF values in 10 out of the 95 investigated ADME core gene loci. Among loci which have extraordinary MAFs in Roma population two have strong proof of clinical importance: rs1799853 (CYP2C9) for warfarin dosage, and rs12248560 (CYP2C19) for clopidogrel dosage, efficacy and toxicity. This finding confirms the importance of taking the Roma as well as the other isolated populations`genetic profiles into account in pharmaco-therapeutic practice.
Competing Interests: The authors have declared that no competing interests exist.
- References:
Am J Phys Anthropol. 2009 Mar;138(3):333-42. (PMID: 18785634)
Biomed Rep. 2014 Jul;2(4):463-476. (PMID: 24944790)
Thromb Res. 2007;120(1):1-10. (PMID: 17161452)
Lipids Health Dis. 2014 Sep 05;13:145. (PMID: 25189712)
PLoS One. 2017 Feb 17;12(2):e0172407. (PMID: 28212442)
Drug Metab Rev. 2005;37(3):511-64. (PMID: 16257833)
Genet Test Mol Biomarkers. 2014 Feb;18(2):83-7. (PMID: 24180318)
J Biol Chem. 2005 Sep 9;280(36):31603-7. (PMID: 16030016)
Mol Biol Rep. 2013 Aug;40(8):4727-35. (PMID: 23645039)
J Med Genet. 2014 Sep;51(9):614-22. (PMID: 25074363)
Clin Pharmacol Ther. 2012 Oct;92(4):414-7. (PMID: 22992668)
Nat Commun. 2014 Nov 06;5:5345. (PMID: 25373335)
Cancer Res. 1990 Jun 1;50(11):3367-76. (PMID: 2334931)
Pharmacogenomics. 2008 Jan;9(1):19-33. (PMID: 18154446)
BMC Genet. 2008 Feb 27;9:21. (PMID: 18304320)
Pharmacogenomics. 2009 Jun;10(6):1025-32. (PMID: 19530970)
Pharmacogenet Genomics. 2016 Mar;26(3):116-25. (PMID: 26641474)
BMC Genomics. 2012 Mar 22;13:107. (PMID: 22439654)
Pharmacogenomics J. 2014 Jun;14(3):217-22. (PMID: 23835662)
BMC Med Genet. 2017 Jul 6;18(1):70. (PMID: 28683740)
Pharmacogenomics. 2017 Nov;18(17):1575-1587. (PMID: 29095103)
Pharmacogenomics. 2011 Oct;12(10):1397-406. (PMID: 21902501)
Brief Funct Genomics. 2014 Sep;13(5):371-7. (PMID: 25009120)
Drug Metab Pharmacokinet. 2011;26(2):206-15. (PMID: 21178299)
Clin Pharmacol Ther. 2007 Jan;81(1):76-82. (PMID: 17186002)
Pharmacogenomics J. 2018 Jan;18(1):49-55. (PMID: 28117434)
Basic Clin Pharmacol Toxicol. 2011 Jan;108(1):9-13. (PMID: 20560925)
Lipids Health Dis. 2011 Jan 18;10:9. (PMID: 21244662)
BMC Gastroenterol. 2013 Mar 27;13:57. (PMID: 23537364)
J Hum Genet. 2016 Feb;61(2):119-27. (PMID: 26423926)
Front Pharmacol. 2012 Nov 06;3:191. (PMID: 23133420)
Pharmacogenet Genomics. 2012 Dec;22(12):846-57. (PMID: 23089684)
Hum Genet. 2013 May;132(5):563-77. (PMID: 23354977)
Environ Health Perspect. 2009 Oct;117(10):1541-8. (PMID: 20019904)
J Hum Genet. 2010 Sep;55(9):582-9. (PMID: 20555338)
Forensic Sci Int Genet. 2008 Mar;2(2):e11-3. (PMID: 19083796)
PLoS One. 2012;7(3):e32784. (PMID: 22396794)
PLoS One. 2017 Aug 3;12(8):e0182138. (PMID: 28771511)
Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1895-900. (PMID: 16645157)
PLoS One. 2016 Sep 16;11(9):e0162866. (PMID: 27636550)
Am J Phys Anthropol. 2011 Oct;146(2):262-70. (PMID: 21915846)
EBioMedicine. 2017 Mar;17:67-74. (PMID: 28237373)
Science. 1978 Sep 1;201(4358):786-92. (PMID: 356262)
Hum Mol Genet. 2010 Dec 15;19(24):4813-9. (PMID: 20858603)
Am J Hum Genet. 2004 Oct;75(4):596-609. (PMID: 15322984)
Eur J Clin Pharmacol. 2008 Mar;64(3):257-66. (PMID: 18185926)
BMC Genet. 2015 Sep 03;16:108. (PMID: 26334733)
Hum Genet. 2007 Mar;121(1):23-34. (PMID: 17048007)
BMC Genet. 2017 Aug 31;18(1):82. (PMID: 28859608)
Pharmacogenomics. 2014;15(15):1867-79. (PMID: 25495409)
Genet Test Mol Biomarkers. 2017 Nov;21(11):663-673. (PMID: 28945481)
- Accession Number:
0 (SLCO1B3 protein, human)
0 (Solute Carrier Organic Anion Transporter Family Member 1B3)
5Q7ZVV76EI (Warfarin)
A74586SNO7 (Clopidogrel)
EC 1.14.14.1 (CYP2C19 protein, human)
EC 1.14.14.1 (Cytochrome P-450 CYP2C19)
EC 1.14.14.1 (Cytochrome P-450 CYP3A)
EC 1.14.14.55 (CYP3A4 protein, human)
EC 1.17.4.4 (VKORC1 protein, human)
EC 1.17.4.4 (Vitamin K Epoxide Reductases)
EC 2.3.1.5 (Arylamine N-Acetyltransferase)
EC 2.3.1.5 (NAT2 protein, human)
- Publication Date:
Date Created: 20181120 Date Completed: 20190422 Latest Revision: 20190422
- Publication Date:
20231215
- Accession Number:
PMC6242375
- Accession Number:
10.1371/journal.pone.0207671
- Accession Number:
30452466
No Comments.